The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
MET: a promising anticancer therapeutic target
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Sequist, L. V., Waltman, B. A., Dias-Santagata, D., Digumarthy, S., Turke, A. B., Fidias, P., Bergethon, K., Shaw, A. T., Gettinger, S., Cosper, A. K., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002003 · Cited by 3,499
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Isaacson, P. G., Dogan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,915
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Shaw, A. T., Yeap, B. Y., Mino-Kenudson, M., Digumarthy, S. R., Costa, D. B., Heist, R. S., Solomon, B., Stubbs, H., Admane, S., McDermott, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6993 · Cited by 1,870
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
Scatter factor/hepatocyte growth factor is essential for liver development
Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., & Birchmeler, C. (1995) · Nature · doi:10.1038/373699a0 · Cited by 1,394
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
MET signalling: principles and functions in development, organ regeneration and cancer
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3012 · Cited by 1,240
Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710052104 · Cited by 1,075
Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC
Turke, A. B., Zejnullahu, K., Wu, Y.-L., Song, Y., Dias-Santagata, D., Lifshits, E., Toschi, L., Rogers, A., Mok, T., Sequist, L., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.022 · Cited by 1,059
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., & Kitamura, N. (1995) · Nature · doi:10.1038/373702a0 · Cited by 1,041
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Comoglio, P. M., Giordano, S., & Trusolino, L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2530 · Cited by 818
Zou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Cappuzzo, F., Marchetti, A., Skokan, M., Rossi, E., Gajapathy, S., Felicioni, L., del Grammastro, M., Sciarrotta, M. G., Buttitta, F., Incarbone, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1635 · Cited by 557
Kurzrock, R., Sherman, S. I., Ball, D. W., Forastiere, A. A., Cohen, R. B., Mehra, R., Pfister, D. G., Cohen, E. E. W., Janisch, L., Nauling, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.4145 · Cited by 550
A mouse model for EML4-ALK -positive lung cancer
Soda, M., Takada, S., Takeuchi, K., Choi, Y. L., Enomoto, M., Ueno, T., Haruta, H., Hamada, T., Yamashita, Y., Ishikawa, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805381105 · Cited by 512
Novel mutations of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202547 · Cited by 497
Nakajima, M., Sawada, H., Yamada, Y., Watanabe, A., Tatsumi, M., Yamashita, J., Matsuda, M., Sakaguchi, T., Hirao, T., & Nakano, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990501)85:9%3c1894::aid-cncr3%3e3.0.co;2-j · Cited by 494
Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
Kong-Beltran, M., Seshagiri, S., Zha, J., Zhu, W., Bhawe, K., Mendoza, N., Holcomb, T., Pujara, K., Stinson, J., Fu, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2749 · Cited by 490
Smolen, G. A., Sordella, R., Muir, B., Mohapatra, G., Barmettler, A., Archibald, H., Kim, W. J., Okimoto, R. A., Bell, D. W., Sgroi, D. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508776103 · Cited by 485
Robert, F., Ezekiel, M. P., Spencer, S. A., Meredith, R. F., Bonner, J. A., Khazaeli, M. B., Saleh, M. N., Carey, D., LoBuglio, A. F., Wheeler, R. H., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3234 · Cited by 474
Renzo, M. F. D., Olivero, M., Giacomini, A., Porte, H., Chastre, E., Mirossay, L., Nordlinger, B., Bretti, S., Bottardi, S., & Giordano, S. (1995) · PubMed · Cited by 471
Ma, P. C., Kijima, T., Maulik, G., Fox, E. A., Sattler, M., Griffin, J. D., Johnson, B. E., & Salgia, R. (2003) · PubMed · Cited by 454
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., & Nakamura, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10226 · Cited by 434
Ou, S.-H. I., Kwak, E. L., Siwak-Tapp, C., Dy, J., Bergethon, K., Clark, J. W., Camidge, D. R., Solomon, B. J., Maki, R. G., Bang, Y.-J., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31821528d3 · Cited by 432
Sequist, L. V., von Pawel, J., Garmey, E. G., Akerley, W. L., Brugger, W., Ferrari, D., Chen, Y., Costa, D. B., Gerber, D. E., Orlov, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0570 · Cited by 378
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
Matsumoto, K., & Nakamura, T. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00717.x · Cited by 353
Qian, F., Engst, S., Yamaguchi, K., Yu, P., Won, K.-A., Mock, L., Lou, T., Tan, J., Li, C., Tam, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4889 · Cited by 350
Zhao, X., Weir, B. A., LaFramboise, T., Lin, M., Beroukhim, R., Garraway, L., Beheshti, J., Lee, J. C., Naoki, K., Richards, W. G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4603 · Cited by 337
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey, P. A., Zhu, X., Zarnegar, R., Swanson, P. E., Ratliff, T. L., Vollmer, R. T., & Day, M. L. (1995) · Europe PMC (PubMed Central) · Cited by 335
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Di Renzo, M. F., Olivero, M., Martone, T., Maffe, A., Maggiora, P., De Stefani, A., Valente, G., Giordano, S., Cortesina, G., & Comoglio, P. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203455 · Cited by 332
Frequent amplification of the c-met gene in scirrhous type stomach cancer
Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., & Tahara, E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91548-5 · Cited by 328
Munshi, N., Jeay, S., Li, Y., Chen, C.-R., France, D. S., Ashwell, M. A., Hill, J., Moussa, M. M., Leggett, D. S., & Li, C. J. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1173 · Cited by 326
Met and hepatocyte growth factor/scatter factor expression in human gliomas.
Koochekpour, S., Jeffers, M., Rulong, S., Taylor, G., Klineberg, E. O., Hudson, E. A., Resau, J. H., & Woude, G. F. V. (1997) · PubMed · Cited by 320
A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo
Martens, T., Schmidt, N.-O., Eckerich, C., Fillbrandt, R., Merchant, M., Schwall, R., Westphal, M., & Lamszus, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1418 · Cited by 305
Yamashita, J.-I., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T., & Shin, S.-I. (1994) · PubMed · Cited by 298
Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280
C-met Proto-Oncogene Expression in Benign and Malignant Human Prostate Tissues
Pisters, L. L., Troncoso, P., Zhau, H. E., Li, W., von Eschenbach, A. C., & Chung, L. W. K. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67297-5 · Cited by 269
Liu, X., Wang, Q., Yang, G., Marando, C., Koblish, H. K., Hall, L. M., Fridman, J. S., Behshad, E., Wynn, R., Li, Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1157 · Cited by 265
VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
You, W.-K., Sennino, B., Williamson, C. W., Falcón, B., Hashizume, H., Yao, L.-C., Aftab, D. T., & McDonald, D. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2527 · Cited by 259
Sawada, K., Radjabi, A. R., Shinomiya, N., Kistner, E., Kenny, H., Becker, A. R., Turkyilmaz, M. A., Salgia, R., Yamada, S. D., Vande Woude, G. F., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1147 · Cited by 258
Burgess, T., Coxon, A., Meyer, S., Sun, J., Rex, K., Tsuruda, T., Chen, Q., Ho, S.-Y., Li, L., Kaufman, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3329 · Cited by 252
Park, W. S., Dong, S. M., Kim, S. Y., Na, E. Y., Shin, M. S., Pi, J. H., Kim, B. J., Bae, J. H., Hong, Y. K., Lee, K. S., et al. (1999) · PubMed · Cited by 251
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck, A. B., Park, M., Sterns, E. E., Boag, A., & Elliott, B. E. (1996) · Europe PMC (PubMed Central) · Cited by 244
Hepatocyte growth factor, a versatile signal for developing neurons
Maina, F., & Klein, R. (1999) · Nature Neuroscience · doi:10.1038/6310 · Cited by 234
Jin, H., Yang, R., Zheng, Z., Romero, M., Ross, J., Bou-Reslan, H., Carano, R. A. D., Kasman, I., Mai, E., Young, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5960 · Cited by 220
High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer
Go, H., Jeon, Y. K., Park, H. J., Sung, S.-W., Seo, J.-W., & Chung, D. H. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181ce3d1d · Cited by 218
Elevated Serum Concentrations of Hepatocyte Growth Factor in Patients With Multiple Myeloma
Seidel, C., Børset, M., Turesson, I., Abildgaard, N., Sundan, A., & e Nordic Myeloma Study Group, A. W. F. T. (1998) · Blood · doi:10.1182/blood.v91.3.806 · Cited by 214
Crosstalk in Met receptor oncogenesis
Lai, A. Z., Abella, J. V., & Park, M. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.07.002 · Cited by 213
Hepatocyte growth factor and its receptor c-met in multiple myeloma
Borset, M., Hjorth-Hansen, H., Seidel, C., Sundan, A., & Waage, A. (1996) · Blood · doi:10.1182/blood.v88.10.3998.bloodjournal88103998 · Cited by 209
Ichimura, E., Maeshima, A., Nakajima, T., & Nakamura, T. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb03111.x · Cited by 201
Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma
Jagadeeswaran, R., Ma, P. C., Seiwert, T. Y., Jagadeeswaran, S., Zumba, O., Nallasura, V., Ahmed, S., Filiberti, R., Paganuzzi, M., Puntoni, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4567 · Cited by 198
Eder, J. P., Shapiro, G. I., Appleman, L. J., Zhu, A. X., Miles, D., Keer, H., Cancilla, B., Chu, F., Hitchcock-Bryan, S., Sherman, L., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0574 · Cited by 197
Yap, T. A., Olmos, D., Brunetto, A. T., Tunariu, N., Barriuso, J., Riisnaes, R., Pope, L., Clark, J., Futreal, A., Germuska, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.0367 · Cited by 196
Spigel, D. R., Ervin, T. J., Ramlau, R., Daniel, D. B., Goldschmidt, J. H., Blumenschein, G. R., Krzakowski, M. J., Robinet, G., Clement-Duchene, C., Barlesi, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.7505 · Cited by 193
Wu, Z., Wu, Q., Wang, C., Wang, X., Huang, J., Zhao, J., Mao, S., Zhang, G., Xu, X., & Zhang, N. (2011) · Cancer · doi:10.1002/cncr.25860 · Cited by 192
Prognostic significance of c‐Met expression in glioblastomas
Kong, D., Song, S., Kim, D., Joo, K. M., Yoo, J., Koh, J. S., Dong, S. M., Suh, Y., Lee, J., Park, K., et al. (2009) · Cancer · doi:10.1002/cncr.23972 · Cited by 187
Benedettini, E., Sholl, L. M., Peyton, M., Reilly, J., Ware, C., Davis, L., Vena, N., Bailey, D., Yeap, B. Y., Fiorentino, M., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090863 · Cited by 185
c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases
Zeng, Z.-S., Weiser, M. R., Kuntz, E., Chen, C.-T., Khan, S. A., Forslund, A., Nash, G. M., Gimbel, M., Yamaguchi, Y., Culliford, A. T., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.049 · Cited by 180
Wen, P. Y., Schiff, D., Cloughesy, T. F., Raizer, J. J., Laterra, J., Smitt, M., Wolf, M., Oliner, K. S., Anderson, A., Zhu, M., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq198 · Cited by 173
Webb, C. P., Hose, C. D., Koochekpour, S., Jeffers, M., Oskarsson, M. K., Sausville, E. A., Monks, A. P., & Woude, G. F. V. (2000) · PubMed · Cited by 168
Expression of scatter factor and c‐ met receptor in benign and malignant breast tissue
Jin, L., Fuchs, A., Schnitt, S. J., Yao, Y., Joseph, A., Lamszus, K., Park, M., Goldberg, I. D., & Rosen, E. M. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<749::aid-cncr12>3.0.co;2-# · Cited by 164
Gordon, M. S., Sweeney, C. J., Mendelson, D. S., Eckhardt, S. G., Anderson, A., Beaupre, D. M., Branstetter, D., Burgess, T. L., Coxon, A., Deng, H., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1365 · Cited by 162
McDermott, U., Pusapati, R. V., Christensen, J. G., Gray, N. S., & Settleman, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3620 · Cited by 161
Miller, C. T., Lin, L., Casper, A. M., Lim, J., Thomas, D. G., Orringer, M. B., Chang, A. C., Chambers, A. F., Giordano, T. J., Glover, T. W., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209057 · Cited by 161
Kammula, U. S., Kuntz, E. J., Francone, T. D., Zeng, Z., Shia, J., Landmann, R. G., Paty, P. B., & Weiser, M. R. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.07.007 · Cited by 160
Camp, R. L., Rimm, E. B., & Rimm, D. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2 · Cited by 157
Hammerman, P. S., Janne, P. A., & Johnson, B. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0189 · Cited by 156
Schiering, N., Knapp, S., Marconi, M., Flocco, M. M., Cui, J., Perego, R., Rusconi, L., & Cristiani, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734128100 · Cited by 156
Gene amplification in gastric and esophageal adenocarcinomas.
Houldsworth, J., Cordon‐Cardo, C., Ladanyi, M., Kelsen, D. P., & Chaganti, R. S. K. (1990) · PubMed · Cited by 156
c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma
Puri, N., Ahmed, S., Janamanchi, V., Tretiakova, M., Zumba, O., Krausz, T. N., Jagadeeswaran, R., & Salgia, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0776 · Cited by 155
Kim, K. J., Wang, L., Su, Y.-C., Gillespie, G. Y., Salhotra, A., Lal, B., & Laterra, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1793 · Cited by 150
In Vivo Specific Delivery of c-Met siRNA to Glioblastoma Using Cationic Solid Lipid Nanoparticles
Jin, J., Bae, K. H., Yang, H., Lee, S. J., Kim, H., Kim, Y., Joo, K. M., Seo, S. W., Park, T. G., & Nam, D. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200406n · Cited by 149
Krumbach, R., Schüler, J. B., Hofmann, M., Giesemann, T., Fiebig, H., & Beckers, T. L. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.12.019 · Cited by 147
Daveau, M., Scotté, M., François, A., Coulouarn, C., Ros, G., Tallet, Y., Hiron, M., Hellot, M., & Salier, J. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10103 · Cited by 146
Jun, H. T., Sun, J., Rex, K. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2969 · Cited by 146
c‐Met activation in lung adenocarcinoma tissues: An immunohistochemical analysis
Nakamura, Y., Niki, T., Goto, A., Morikawa, T., Miyazawa, K., Nakajima, J., & Fukayama, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00493.x · Cited by 145
Eathiraj, S., Palma, R., Volckova, E., Hirschi, M., France, D. S., Ashwell, M. A., & Chan, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213801 · Cited by 140
Showering c-MET-dependent cancers with drugs
Knudsen, B. S., & Woude, G. V. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.02.001 · Cited by 137
Buchanan, S. G., Hendle, J., Lee, P. S., Smith, C. R., Bounaud, P., Jessen, K., Tang, C. M., Huser, N. H., Felce, J. D., Froning, K., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0477 · Cited by 135
Børset, M., Lien, E., Espevik, T., Helseth, E., Waage, A., & Sundan, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24655 · Cited by 131
Edakuni, G., Sasatomi, E., Satoh, T., Tokunaga, O., & Miyazaki, K. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01182.x · Cited by 130
Xu, H., Stabile, L. P., Gubish, C. T., Gooding, W. E., Grandis, J. R., & Siegfried, J. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3339 · Cited by 130
Scatter factor expression and regulation in human glial tumors
Rosen, E. M., Laterra, J., Joseph, A., Jin, L., Fuchs, A., Way, D., Witte, M. H., Weinand, M. E., & Goldberg, I. D. (1996) · International Journal of Cancer · Cited by 126
Ferracini, R., Olivero, M., Renzo, M. F. D., Martano, M., Giovanni, C. D., Nanni, P., Basso, G., Scotlandi, K., Lollini, P., & Comoglio, P. M. (1996) · PubMed · Cited by 122
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer
Graveel, C. R., DeGroot, J. D., Su, Y., Koeman, J. M., Dykema, K. J., Leung, S. C. Y., Snider, J., Davies, S. R., Swiatek, P. J., Cottingham, S. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810403106 · Cited by 116
Tong, C. Y., Hui, A. B., Yin, X.-L., Pang, J. C., Zhu, X.-L., Poon, W. S., & Ng, H. (2004) · Journal of Neurosurgery Pediatrics · doi:10.3171/ped.2004.100.2.0187 · Cited by 116
Aishima, S., Taguchi, K., Sugimachi, K., Shimada, M., Sugimachi, K., & Tsuneyoshi, M. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.00353.x · Cited by 116
Tolnay, E., Kuhnen, C., Wiethege, T., König, J. E., Voß, B., & Müller, K.-M. (1998) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050171 · Cited by 113
Hussain, M., Smith, M. R., Sweeney, C. J., Corn, P. G., Elfiky, A. A., Gordon, M. S., Haas, N. B., Harzstark, A. L., Kurzrock, R., Lara, P. N., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.4516 · Cited by 111
Ide, T., Kitajima, Y., Miyoshi, A., Ohtsuka, T., Mitsuno, M., Ohtaka, K., & Miyazaki, K. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9435-3 · Cited by 110
Tjin, E. P. M., Groen, R. W. J., Vogelzang, I., Derksen, P. W. B., Klok, M. D., Meijer, H. P., van Eeden, S., Pals, S. T., & Spaargaren, M. (2005) · Blood · doi:10.1182/blood-2005-05-1929 · Cited by 96
Effect of c-Met Expression on Survival in Head and Neck Squamous Cell Carcinoma
Muzio, L. L., Farina, A., Rubini, C., Coccia, E., Capogreco, M., Colella, G., Leonardi, R. M., Campisi, G., & Carinci, F. (2006) · Tumor Biology · doi:10.1159/000092716 · Cited by 84
Papotti, M. G., Olivero, M., Volante, M., et al. (2000) · Endocrine Pathology · doi:10.1385/ep:11:1:19 · Cited by 83
Nabeshima, K., Shimao, Y., Sato, S., Kataoka, H., MORIYAMA, T., Kawano, H., Wakisaka, S., & Koono, M. (1997) · Histopathology · doi:10.1046/j.1365-2559.1997.3010889.x · Cited by 82
Harvey, P., Warn, A., NEWMAN, P., Perry, L. J. P., Ball, R. Y., & Warn, R. M. (1996) · The Journal of Pathology · Cited by 81
Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease
Teofili, L., Febo, A. D., Pierconti, F., Maggiano, N., Bendandi, M., Rutella, S., Cingolani, A., Renzo, N. D., Musto, P., Pileri, S. A., et al. (2001) · Blood · doi:10.1182/blood.v97.4.1063 · Cited by 79
Activation of c‐Met (hepatocyte growth factor receptor) in human gastric cancer tissue
Inoué, T., Kataoka, H., Goto, K., Nagaike, K., Igami, K., Naka, D., Kitamura, N., & Miyazawa, K. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02185.x · Cited by 78
Baykal, C. M., Ayhan, A., Al, R. A., Yuce, K., & Ayhan, A. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(02)00073-2 · Cited by 77
MET Receptor Tyrosine Kinase Sequence Alterations in Differentiated Thyroid Carcinoma
Wasenius, V.-M., Hemmer, S., Karjalainen‐Lindsberg, M., Nupponen, N. N., Franssila, K., & Joensuu, H. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000156103.37756.e2 · Cited by 75
Okamoto, W., Okamoto, I., Tanaka, K., Hatashita, E., Yamada, Y., Kuwata, K., Yamaguchi, H., Arao, T., Nishio, K., Fukuoka, M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0481 · Cited by 74
Adjei, A. A., Schwartz, B., & Garmey, E. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0380 · Cited by 73
Self-citationMoriyama, T., Kataoka, H., Tsubouchi, H., & Koono, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00949-a · Cited by 71
Rosen, P. J., Sweeney, C. J., Park, D. J., Beaupre, D. M., Deng, H., Leitch, I. M., Shubhakar, P., Zhu, M., Oliner, K. S., Anderson, A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2862 · Cited by 71
Miyata, Y., Sagara, Y., Kanda, S., et al. (2009) · Human Pathology · doi:10.1016/j.humpath.2008.09.011 · Cited by 70
Expression of c-met Proto-oncogene in Primary Colorectal Cancer and Liver Metastases
Fujita, S., & Sugano, K. (1997) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/27.6.378 · Cited by 68
Jücker, M., Günther, A., Gradl, G., et al. (1994) · Leukemia Research · doi:10.1016/0145-2126(94)90003-5 · Cited by 67
Wen, P. Y., Prados, M. D., Schiff, D., Reardon, D. A., Cloughesy, T. F., Mikkelsen, T., Batchelor, T. T., Drappatz, J., Chamberlain, M. C., & de Groot, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.2006 · Cited by 67
Yılmaz, P. T., Kıratlı, H., Sağlam, A., Söylemezoğlu, F., & Hasçelik, G. (2010) · Melanoma Research · doi:10.1097/cmr.0b013e328335a916 · Cited by 65
Wakelee, H. A., Gettinger, S. N., Engelman, J. A., Janne, P. A., West, H., Subramaniam, D. S., Leach, J. W., Wax, M., Yaron, Y., & Lara, P. N. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.3017 · Cited by 63
Overexpression of scatter factor and its receptor (c‐met) in oral squamous cell carcinoma
Marshall, D. D., & Rornberg, L. J. (1998) · The Laryngoscope · doi:10.1097/00005537-199809000-00031 · Cited by 56
Hepatocyte Growth Factor Receptor in Acute Tubular Necrosis
Rabkin, R., Fervenza, F. C., Tsao, T., Sibley, R. K., Friedlaender, M. M., Hsu, F. W., Lassman, C., Hausmann, M., Huie, P., & SCHWALL, R. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123531 · Cited by 55
Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions
Ellis, P. M., & Alsaleh, K. A. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2012.02.004 · Cited by 49
Buchanan, I. M., Scott, T., Tandle, A. T., Burgan, W. E., Burgess, T. L., Tofilon, P. J., & Camphausen, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01122.x · Cited by 48
Verstovšek, S., Kantarjian, H. M., Estey, E. H., Aguayo, A., Giles, F. J., Manshouri, T., Koller, C. A., Estrov, Z. E., Freireich, E. J., Keating, M. J., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402182 · Cited by 47
Inhibition of Src Impairs the Growth of Met-Addicted Gastric Tumors
Bertotti, A., Bracco, C., Girolami, F., Torti, D., Gastaldi, S., Galimi, F., Medico, E., Elvin, P., Comoglio, P., & Trusolino, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0106 · Cited by 47
Humphrey, P. A., Halabi, S., Picus, J., Sanford, B. L., Vogelzang, N. J., Small, E. J., & Kantoff, P. W. (2006) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2006.n.006 · Cited by 43
Wu, F., WU, L., Zheng, S., Ding, W., Teng, L., Wang, Z., Ma, Z., & ZHAO, W. (2006) · Digestive and Liver Disease · doi:10.1016/j.dld.2006.03.007 · Cited by 42
Walker, F., Kermorgant, S., Daraï, É., Madélénat, P., Crémieux, A. C., Hénin, D., & Lehy, T. (2003) · PubMed · Cited by 37
Eng, C., Cutsem, E. V., Nowara, E., Świeboda-Sadlej, A., Tebbutt, N. C., Mitchell, E. P., Давиденко, І., Oliner, K. S., Chen, L., Huang, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.3500 · Cited by 37
Tan, E. H., Park, K., Lim, W. T., Ahn, M., Ng, Q. S., Ahn, J. S., Tan, D. S., Sun, J., Jac, J., Han, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.7571 · Cited by 36
Stabile, L. P., Rothstein, M. E., Keohavong, P., Lenzner, D. E., Land, S. R., Gaither‐Davis, A., Kim, K. J., Kaminski, N., & Siegfried, J. M. (2010) · Cancers · doi:10.3390/cancers2042153 · Cited by 35
Wang, P., Nishitani, M., Tanimoto, S., et al. (2007) · Urology · doi:10.1016/j.urology.2007.01.063 · Cited by 34
Jones, S. F., Cohen, R. B., Bendell, J. C., Denlinger, C. S., Harvey, R. D., Parasuraman, S., Chi, X., Scholz, C. R., Wyant, T., & Kauh, J. S. W. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.3081 · Cited by 27
Evaluation of the tyrosine kinase domain of theMet Proto-oncogene in sporadic ovarian carcinomas
Tanyi, J. L., Tory, K., Rigó, J. J., Nagy, B., & Papp, Z. (1999) · Pathology & Oncology Research · doi:10.1053/paor.1999.0219 · Cited by 25
Missense Mutation of the MET Gene Detected in Human Glioma
Moon, Y.-W., Weil, R. J., Pack, S., Park, W.-S., Pak, E. D., Pham, T., Karkera, J. D., Kim, H.-K., Vortmeyer, A. O., Fuller, B. G., et al. (2000) · Modern Pathology · doi:10.1038/modpathol.3880177 · Cited by 22
Sennino, B., Naylor, R. M., Tabruyn, S. P., You, W., Aftab, D. T., & McDonald, D. M. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.targ-09-a13 · Cited by 21
Role of hepatocyte growth factor and its receptorc-met in multiple myeloma
Seidel, C., Børset, M., Hjorth‐Hansen, H., Sundan, A., & Waage, A. (1998) · Medical Oncology · doi:10.1007/bf02821933 · Cited by 20
Samuelson, E., Levan, K., Adamović, T., et al. (2008) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.11.006 · Cited by 19
Zhelyazkova, A., Tonchev, A. B., Kolova, P., Ivanova, L. V., & Gercheva, L. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701854991 · Cited by 19
Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met
Tsukasaki (1992) · International Journal of Oncology · doi:10.3892/ijo_00000055 · Cited by 13
Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met
Onimaru, Y. (2008) · Institutional Repositories DataBase (IRDB) · Cited by 9
Hori, A., Kitahara, O., Ito, Y., Nishizawa, S., Misumi, Y., & Inaoka, T. (2009) · Cancer Research · Cited by 5
Cited by
Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
Bardelli, A., Corso, S., Bertotti, A., Hobor, S., Valtorta, E., Siravegna, G., Sartore-Bianchi, A., Scala, E., Cassingena, A., Zecchin, D., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0558 · Cited by 657
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
Morgan, P., Brown, D. G., Lennard, S., Anderton, M. J., Barrett, J. C., Eriksson, U., Fidock, M., Hamrén, B., Johnson, A., March, R. E., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.244 · Cited by 452
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
Zhou, L., Liu, X.-D., Sun, M., Zhang, X., German, P., Bai, S., Ding, Z., Tannir, N., Wood, C. G., Matin, S. F., et al. (2016) · Oncogene · doi:10.1038/onc.2015.343 · Cited by 395
Catenacci, D. V. T., Tebbutt, N. C., Davidenko, I., Murad, A. M., Al-Batran, S.-E., Ilson, D. H., Tjulandin, S., Gotovkin, E., Karaszewska, B., Bondarenko, I., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30566-1 · Cited by 348
The role of photodynamic therapy in overcoming cancer drug resistance
Spring, B. Q., Rizvi, I., Xu, N., & Hasan, T. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp00495g · Cited by 335
Metadata
- Authors
- Peters, S., & Adjei, A. A.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2012-05-08
- Volume
- 9
- Issue
- 6
- Pages
- 314-326
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W1974058738
- Cited by
- 280
- References
- 137
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.